Patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are at high risk of liver disease progression. We report a favorable safety profile and SVR12 rates of 96.7% among HIV/HCV coinfected patients participating in an Italian compassionate-use program of ombitasvir/ paritaprevir/ritonavir + dasabuvir (OBV/PTV/r + DSV) ± ribavirin (RBV).
Massimo, A., Teti, E., Antinori, A., Milazzoi, L., Sollima, S., Rizzardini, G., et al. (2017). Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program. CLINICAL INFECTIOUS DISEASES, 64(5), 680-683 [10.1093/cid/ciw846].
Citazione: | Massimo, A., Teti, E., Antinori, A., Milazzoi, L., Sollima, S., Rizzardini, G., et al. (2017). Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program. CLINICAL INFECTIOUS DISEASES, 64(5), 680-683 [10.1093/cid/ciw846]. | |
Tipo: | Articolo in rivista - Articolo scientifico | |
Carattere della pubblicazione: | Scientifica | |
Presenza di un coautore afferente ad Istituzioni straniere: | No | |
Titolo: | Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program | |
Autori: | Massimo, A; Teti, E; Antinori, A; Milazzoi, L; Sollima, S; Rizzardini, G; Di Biagio, A; Saracino, A; Bruno, R; Borghi, V; De Luca, A; Cattelan, A; Hasson, H; Taliani, G; Monforte, A; Mastroianni, C; Di Perri, G; Bigoni, S; Puoti, M; Spinetti, A; Gori, A; Boffa, N; Bruno, C; Giacometti, A; Parruti, G; Vullo, V; Chirianni, A; Pennica, A; Pasquazzi, C; Segala, D; Sarmati, L | |
Autori: | ||
Data di pubblicazione: | 2017 | |
Lingua: | English | |
Rivista: | CLINICAL INFECTIOUS DISEASES | |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1093/cid/ciw846 | |
Appare nelle tipologie: | 01 - Articolo su rivista |